Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    0.00 (0.00%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Acquisition

5 Dec 2016 07:00

RNS Number : 8831Q
Helios Underwriting Plc
05 December 2016
 

5 December 2016

 

Helios Underwriting plc

("Helios" or the "Company")

 

Acquisition of Salviscount LLP

 

 

Acquisition of Salviscount LLP

 

Helios is pleased to announce that, in line with its strategy of increasing underwriting capacity through acquisition, on 2 December 2016 it acquired Salviscoint Limited Liability Partnership (Salviscount), a limited liability member of Lloyd's ("LLV"), for a consideration of £0.8 million in cash. The 2016 underwriting capacity of Salviscount is £1.0 million (this compares with Helios's 2016 capacity of £32.7 million prior to this acquisition). Salviscount participates in a spread of Lloyd's syndicates broadly similar to Helios's own participation. The capacity acquired, which Helios expects to retain, is as follows:

 

 Salviscount LLP

 

Year of Account

 

 

2014

2015

2016

 

£m

£m

£m

Retained

1.08

0.9

1.0

Reinsured

-

-

-

Total Capacity

1.08

0.9

1.0

 

 

Commenting upon the acquisition, Nigel Hanbury, the Company's Chief Executive Officer, said:

"We are delighted to have made a further acquisition which further increases our underwriting capacity. This is in line with our stated strategy of acquiring corporate members as suitable opportunities arise. We continue to believe that there remain significant opportunities for further growth available to the Company."

 

Additional information

Salviscount LLP (Salviscount) is a limited liability member of Lloyd's. In the year ended 31 December 2015, Salviscount made a profit before tax of £0.118m on gross premiums written of £0.881m and its net asset value at completion is expected to be approximately £0.8m, including underwriting capacity with an estimated market value of £0.4m.

 

 

Set out below are Salviscount's 2014 and 2015 open years of account forecasts:

 

YOA

Salviscount

syndicate capacity

(£'000)

Forecast of syndicate profit

(30 September 2016)

Mid point

(£'000)

Mid point

(%)

Range

(%)

2014

1,084

123

11.37

14.77% - 7.97%

2015

936

67

7.2%

11.19% - 3.20%

 

Source: Syndicate data and Helios analysis (before early release)

 

 

 

For further information please contact:

 

Helios

Nigel Hanbury - Chief Executive

Arthur Manners

 

020 7863 6655 / nigel.hanbury@huwplc.com

07754 965 917

 

 

Stockdale

Robert Finlay

 

 

020 7601 6100

 

 

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £32 million of capacity for the 2016 account. The portfolio provides a good spread of classes of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQTTBRTMBJMBIF
Date   Source Headline
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in own shares
23rd Aug 202311:44 amRNSShare Repurchase Programme
21st Aug 20234:23 pmRNSNotification of Major Holdings
21st Aug 202311:40 amRNSDirector's Shareholding
18th Aug 20238:22 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20234:30 pmRNSShare Repurchase Programme
2nd Aug 20237:00 amRNSTotal Voting Rights
25th Jul 20237:00 amRNSAcquisition
14th Jul 20237:00 amRNSDirector Dealing
14th Jul 20237:00 amRNSAcquisition of Limited Liability Vehicle
13th Jul 20237:00 amRNSIssue of Equity
4th Jul 20237:00 amRNSResults of Scrip Dividend Election
29th Jun 20233:46 pmRNSDirectorship Change
29th Jun 202311:27 amRNSResults of Annual General Meeting
29th Jun 20237:00 amRNSNotification of Major Holdings
16th Jun 20237:00 amRNSScrip Dividend Reference Price
7th Jun 20233:53 pmRNSDirector’s Shareholding
5th Jun 20233:39 pmRNSFinal Dividend Timetable
5th Jun 20237:00 amRNSDirector’s/PCA Shareholdings
1st Jun 20237:00 amRNSGrant of LTIP Award
31st May 20237:00 amRNSPosting of Annual Report and Notice of AGM
31st May 20237:00 amRNSQuarterly Syndicate Mid-Point Forecasts
26th May 20237:00 amRNSFinal Results
12th May 20237:00 amRNSChange of Adviser
11th May 20237:00 amRNSDirectors' Disclosure
11th Apr 20237:00 amRNSDirector's/PCAs' Shareholding
5th Apr 20237:00 amRNSGrant of LTIP Award and Director Dealing
5th Apr 20237:00 amRNSDirector/PCA Shareholdings
4th Apr 20237:00 amRNSDirectorate Change
4th Apr 20237:00 amRNSQuarterly Syndicate Mid Point Forecasts
10th Jan 20237:00 amRNS2023 Helios Retained Capacity Update
29th Dec 20223:38 pmRNSAcquisitions of LLVs, Issue of Equity and TVR
20th Dec 20227:00 amRNSHolding(s) in Company
19th Dec 202212:06 pmRNSHolding(s) in Company
19th Dec 20229:07 amRNSGrant of LTIP Awards and Directors' Dealings
14th Dec 202212:47 pmRNSHolding(s) in Company
13th Dec 202211:29 amRNSResult of GM, TVR and Directors' Participation
12th Dec 20227:00 amRNSResult of Open Offer
24th Nov 202212:54 pmRNSReplacement - Result of Placing and Subscription
24th Nov 20227:00 amRNSResult of Placing and Subscription
23rd Nov 20224:45 pmRNSFundraising to raise up to approximately £13.5m
29th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSQuarterly Syndicate Mid Point Forecasts
29th Jun 20221:13 pmRNSResult of AGM
1st Jun 20222:31 pmRNSPosting of Annual Report and Notice of AGM
27th May 20227:00 amRNSFinal Results
23rd May 20229:10 amRNSQuarterly Syndicate Mid Point Forecasts
8th Apr 20227:00 amRNSPCA Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.